Rapid progression from subclinical to symptomatic overt hypothyroidism

Endocrine Practice

Volumn 11, Issue 2, 2005, Pages 115-119

  Heymann, Robert ^a   Brent, Gregory A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; LEVOTHYROXINE; LIOTHYRONINE; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

AGED; ANAMNESIS; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG EXPOSURE; DRUG INDICATION; FREE THYROXINE INDEX; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; LIOTHYRONINE BLOOD LEVEL; MALE; MEDICAL CARE; MEDICAL DECISION MAKING; MEDICAL RECORD; PATIENT MONITORING; PEROXIDASE ANTIPEROXIDASE COMPLEX; PHYSICAL EXAMINATION; RISK FACTOR; THYROTROPIN BLOOD LEVEL;

EID: 18744384956     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.11.2.115     Document Type: Article

References (22)

1. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996;335:99-107.
2. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid. 1998;8:803-813.
3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
4. Huber G, Staub JJ, Meier C, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab. 2002;87:3221-3226.
5. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-238.
6. Helfand M (U.S. Preventative Services Task Force). Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventative Services Task Force. Ann Intern Med. 2004; 140:128-141.
7. Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003; 59:396-401.
8. Minelli R, Braverman LE, Giuberti T, et al. Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment. Clin Endocrinol (Oxf). 1997; 47:357-361.
9. Prummel MF, Laurberg P. Interferon-alpha and autoimmune thyroid disease. Thyroid. 2003;13:547-551.
10. Wang SH, Bretz JD, Phelps E, et al. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol. 2002; 168:2470-2474.
11. Col NF, Surks MI, Daniels GH. Subclinical thyroid disease: clinical applications. JAMA. 2004;291:239-243.
12. Cooper DS. Clinical practice: subclinical hypothyroidism. N Engl J Med. 2001;345:260-265.
13. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88:2438-2444.
14. Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid. 2000;10:665-679.
15. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132:270-278.
16. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism: Standards of Care Committee, American Thyroid Association. JAMA. 1995;273:808-812.
17. AACE Thyroid Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002;8:457-469.
18. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43:55-68.
19. Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA. 1987;258:209-213.
20. Erickson AR, Enzenauer RJ, Nordstrom DM, Merenich JA. The prevalence of hypothyroidism in gout. Am J Med. 1994;97:231-234.
21. Giordano N, Santacroce C, Mattii G, Geraci S, Amendola A, Gennari C. Hyperuricemia and gout in thyroid endocrine disorders. Clin Exp Rheumatol. 2001;19: 661-665.
22. Spiro MJ, Gorski KM. Studies on the posttranslational migration and processing of thyroglobulin: use of inhibitors and evaluation of the role of phosphorylation. Endocrinology. 1986;119:1146-1158.